Bortezomib and thrombocytopenia Patient Reports February 12, 2012

Bortezomib Side Effects Report #5723400-6
Bortezomib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Female patient, 69 years of age, weighting 225.0 lb, was diagnosed with multiple myeloma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: constipation , decreased appetite, epistaxis, nasopharyngitis, thrombocytopenia. Bortezomib dosage: 2.6MG OTHER IV. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #4799741-6
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2005. Male patient, weighting 185.2 lb, was diagnosed with multiple myeloma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Bortezomib dosage: 2 MG IV PUSH. During the same period patient was treated with HEPARIN, FUROSEMIDE, WARFARIN, FENTANYL, ZOCOR. Patient recovered.

Bortezomib Side Effects Report #4642356-0
Bortezomib side effect was reported by a Physician from on Apr 20, 2005. Female patient, weighting 124.0 lb, was diagnosed with cervix carcinoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: confusional state, fatigue, hypokalaemia, hyponatraemia, thrombocytopenia. Bortezomib dosage: 1.35 MG/M2 D1,4,8,1 1 Q21D INTRAVENOUS. During the same period patient was treated with IRINOTECAN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #4633802-7
Bortezomib side effect was reported by a Physician from on Apr 12, 2005. Female patient, weighting 124.0 lb, was diagnosed with cervix cancer metastatic and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: confusional state, disease progression, fatigue, hypokalaemia, hyponatraemia, thrombocytopenia. Bortezomib dosage: 1.35 MG/M2 D1, 4,8, 11 Q12D INTRAVENOUS. During the same period patient was treated with IRINOTECAN PFIZER, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.